As of 2025-12-29, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (6.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -171.4%.
The range of the Relative Valuation is (4.82) - (9.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 14.8x | 10.0x |
| Forward P/E multiples | 7.7x - 15.7x | 11.7x |
| Fair Price | (4.82) - (9.24) | (6.78) |
| Upside | -150.8% - -197.2% | -171.4% |
| Date | P/E |